A study of cardivascular risk in type 2 diabetes mellitus

Not yet recruiting

• Conditions: Type 2 diabetes mellitus without complications,

• Registration Number: CTRI/2019/08/020792
• Lead Sponsor: Dr Arshiya

Brief Summary

**INTRODUCTION-** Cardiovasculardisease is the leading cause of mortality worldwide, including in low andmiddle income countries. It is well known that diabetes is associated withincreased cardiovascular morbidity and mortality. Risk factors of type2 diabetes mellitus includesunmodifiable risk factors like age, sex, ethnic status and family history andmodifiable risk factors like weight, smoking, alcohol, hypertension, sedentarylifestyle, hyperlipidaemia and hypercholesterolemia .Estimates of CVD risk canbe useful for both clinicians and patients

**AIMS & OBJECTIVES-** To evaluate thecardiovascular risk score in subjects with type 2 diabetes mellitus

**MATERIALS  & METHODS -** A cross-sectional  observational study  will be  carried in diabetic patients  attending  Medicine OPD /Ward  in  Government Medical  College,  Patiala.Informed  consent  will be   obtained  and the  patients  will be  interviewed  followed by  detail  examination.After fulfilment of inclusion and exclusioncriteria, 10 year Cardiovascular  risk assessment will be done using UKPDS riskengine.

**CLINICAL SIGNIFICANCE**- Estimatesof CVD risk can be useful for both clinicians and patients: for clinicians, itis a prognostic information that can support them in the choice of therapeuticand preventive strategies; and for patients, it can be a motivation tool toadopt healthy lifestyle measures and to observe prescribed risk-modifyingtreatments

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-08-19
• Study Start: 2019-08-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age > 40 years Sex- Both male and female Patients with FBS > 110 mg/dl and HB1ac >8%.

Exclusion Criteria

Children Pregnant women Seriously ill and acutely ill patients Patients who are not willing to give written informed consent.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the cardiovascular risk score in subjects with type 2 diabetes mellitus	4 months

Secondary Outcome Measures

Name	Time	Method
to compare UKPDS and WHO/ISH charts	4 months

Trial Locations

Locations (1)

Government Medical College & Rajindra Hospital; 🇮🇳 Patiala, PUNJAB, India

Government Medical College & Rajindra Hospital

🇮🇳Patiala, PUNJAB, India

Dr Arshiya

Principal investigator

09646732003

arshiyasehgal26@gmail.com